Sandeep Chidambar Kulkarni, CEO at Tourmaline Bio, Inc. (TRML), bought 10,442 shares at $13.79 ($144K) on 2024-08-16, disclosed to the SEC on 2024-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.79 | 5,221 | $72K | 50.0% |
| 2 | $13.79 | 5,221 | $72K | 50.0% |
| Total | $13.79 avg | 10,442 | $144K | 100% |
| Filing → |
| TRML | BUY | 2023-10-26 | $111K | — | Filing → |